Peter Staller
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer-related Molecular Pathways
- Chemokine receptors and signaling
Papers in
-
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 4
- Ubiquitin and proteasome pathways 3
- Histone Deacetylase Inhibitors Research 2
- Oncology 8
- Cancer-related Molecular Pathways 5
- Chemokine receptors and signaling 2
- Co-authors
- Martin Eilers (5 shared papers)Wilhelm Krek (2 shared papers)Holger Moch (2 shared papers)Edward J. Oakeley (1 shared paper)Joanna Lisztwan (1 shared paper)Joan Seoane (2 shared papers)Joan Massagué (2 shared papers)Caroline Bouchard (2 shared papers)
- Journals
- Oncogene (3 papers)Nature Cell Biology (2 papers)Nature (1 paper)Trends in Cell Biology (1 paper)Epigenomics (1 paper)
- Partner nations
- GermanyDenmarkUnited States
In The Last Decade
Peter Staller
13 papers receiving 2.6k citations
Peter Staller's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 642
- Oncology 895
- Molecular Biology 1.9k
- Immunology 361
- Aging 22
Countries citing papers authored by Peter Staller
This map shows the geographic impact of Peter Staller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Staller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Staller more than expected).
Fields of papers citing papers by Peter Staller
This network shows the impact of papers produced by Peter Staller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Staller. The network helps show where Peter Staller may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Staller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL Hit paper breakdown → | 2003 | 744 |
| 2 | 2001 | 481 | |
| 3 | 2001 | 414 | |
| 4 | 2008 | 295 | |
| 5 | 1998 | 215 | |
| 6 | 2013 | 106 | |
| 7 | 2011 | 106 | |
| 8 | 1999 | 100 | |
| 9 | 2014 | 84 | |
| 10 | 1997 | 66 | |
| 11 | 2008 | 64 | |
| 12 | 2018 | 21 | |
| 13 | 2015 | 1 |
About Peter Staller
Peter Staller is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Physiology, having authored 13 papers that have together received 2.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer-related Molecular Pathways (5 papers), Cancer-related gene regulation (4 papers), Ubiquitin and proteasome pathways (3 papers), Chemokine receptors and signaling (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cell Adhesion Molecules Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (642 citations), Oncology (895 citations), Molecular Biology (1.9k citations), Immunology (361 citations) and Aging (22 citations). Peter Staller has collaborated with scholars based in Germany, Denmark and United States. Frequent co-authors include Martin Eilers, Wilhelm Krek, Holger Moch, Edward J. Oakeley, Joanna Lisztwan, Joan Seoane, Joan Massagué, Caroline Bouchard, Célio Pouponnot and K.S. Jensen. Their work appears in journals such as Oncogene, Nature Cell Biology, Nature, Trends in Cell Biology and Epigenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.